|VAS2870 is a specific and effect NADPH oxidase inhibitor with IC50 value of 106 M against NOX activity in human neutrophil lysates
|ML171 is a novel and selective NOX1 inhibitor with IC50 value of 0.25 M for blocking NOX1-dependent ROS generation in a HEK293-NOX1 recombinant cell system.
|GSK2795039 is a small molecule NADPH Oxidase 2 Inhibitor.
|GLX351322 is an inhibitor of NADPH oxidase 4 inhibits hydrogen peroxide production from NOX4-overexpressing cells with an IC50 of 5 M
|GKT137831 is a specific dual Nox1Nox4 inhibitor with Ki of 14040 nM and 11030 nM and a potent inhibitor of fibrosis and hepatocyte apoptosis
|Fluorofenidone attenuates the progression of renal interstitial fibrosis partly by suppressing NADPH oxidase and ECM deposition via the PI3K/Akt signalling pathway, suggesting AKF-PD is a potential novel therapeutic agent against renal fibrosis.
|BJ-1301 is a promising candidate for the management of tumor agiongenesis and growth via inhibition of RTK and NADPH oxidase activities
|APX-115 free base (Ewha-18278 free base) is a potent, orally active pan NADPH oxidase (Nox) inhibitor with Ki values of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2 and Nox4, respectively.
|Apocynin is potent and selective NADPH-oxidase inhibitor with IC50 value of 10 M